Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Andecaliximab/GS-5745 Alone and Combined with mFOLFOX6 in Advanced Gastric and Gastroesophageal Junction Adenocarcinoma: Results from a Phase I Study

Published:2018-04-24 Issue:16 Volume:24 Page:3829-3837
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Shah Manish A.,Starodub Alexander,Sharma Sunil,Berlin Jordan,Patel Manish,Wainberg Zev A.,Chaves Jorge,Gordon Michael,Windsor Kevin,Brachmann Carrie Baker,Huang Xi,Vosganian Greg,Maltzman Julia D.,Smith Victoria,Silverman Jeffrey A.,Lenz Heinz-Josef,Bendell Johanna C.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between immune-related adverse events and the prognosis of patients with gastric cancer treated with nivolumab: a meta-analysis;Frontiers in Oncology;2024-09-05

2. Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal Cancer;Cancers;2024-08-15

3. Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems;Journal of Alzheimer's Disease;2024-07-16

4. Matrix metalloproteinase 9 expression and glioblastoma survival prediction using machine learning on digital pathological images;Scientific Reports;2024-07-02

5. Identification and validation of Cystatin A as a novel promising therapeutic target for gastric cancer;Journal of Gastrointestinal Oncology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP